• Nenhum resultado encontrado

[PDF] Top 20 GLUT 5 is not over-expressed in breast cancer cells and patient breast cancer tissues.

Has 10000 "GLUT 5 is not over-expressed in breast cancer cells and patient breast cancer tissues." found on our website. Below are the top 20 most common "GLUT 5 is not over-expressed in breast cancer cells and patient breast cancer tissues.".

GLUT 5 is not over-expressed in breast cancer cells and patient breast cancer tissues.

GLUT 5 is not over-expressed in breast cancer cells and patient breast cancer tissues.

... staining in normal breast ...that in contrast to GLUT1 which localized to the plasma membrane, all of the samples which were positive for GLUT5 showed cytoplasmic ...staining in neoplastic ... See full document

8

MRI Background Parenchymal Enhancement Is Not Associated with Breast Cancer.

MRI Background Parenchymal Enhancement Is Not Associated with Breast Cancer.

... ultrasound and mammography, of clinical findings without imaging correlate ...discharge) and follow-up of lesions classified as probably benign (corresponding to BI-RADS 0, 3, 4, 5 at conventional ... See full document

12

Clinical applications of circulating tumour cells in breast cancer patients : based on a case report

Clinical applications of circulating tumour cells in breast cancer patients : based on a case report

... collected and analysed from the patient’s ...detected in nearly 60% of metastatic BC, with a median value of 2 ...found in patients with positive ER, multiple bone or both bone and visceral ... See full document

25

Interleukin18  is equally expressed in inflammatory breast cancer and  locally advanced breast cancer : a possible association with chemotherapy response

Interleukin18 is equally expressed in inflammatory breast cancer and locally advanced breast cancer : a possible association with chemotherapy response

... S4 and S5). A stronger positivity (score 2–3) was found in the stroma ...tumor cells (0%, P = 0.004; Table S3) in IBC ...observed in LABC group (50% in the stroma vs 3.5% ... See full document

7

Heparan sulfate mediates trastuzumab effect in breast cancer cells

Heparan sulfate mediates trastuzumab effect in breast cancer cells

... HER2 is a member of the epidermal growth factor family of tyrosine kinase ...HER2 is amplified in approxi- mately 14% of breast cancers in early stages and 25% of metastatic ... See full document

13

Association between 5p12 genomic markers and breast cancer susceptibility: evidence from 19 case-control studies.

Association between 5p12 genomic markers and breast cancer susceptibility: evidence from 19 case-control studies.

... variations in 5p12 influences BC risk remains unclear. rs10941679 and rs4415084 are in a region of high LD as reported by Stacey et al ...9) is the only RefSeq gene in this region. It ... See full document

8

Alterações epigenéticas e do número de cópias do gene SFN em carcinomas mamários

Alterações epigenéticas e do número de cópias do gene SFN em carcinomas mamários

... gene in human cancer, new studies are clearly ...on in vitro approaches by using specific SFN gene disruption assays as well as forced ...epithelial breast and breast ... See full document

104

Radioterapia intraoperatória como protocolo de tratamento do câncer de mama inicial

Radioterapia intraoperatória como protocolo de tratamento do câncer de mama inicial

... early-stage breast cancer based on local recurrence rates and ...≤2.5cm breast tumors and clinically normal axillary lymph nodes were submitted to quadrantectomy, sentinel lymph node ... See full document

7

Cad. Saúde Pública  vol.24 número4

Cad. Saúde Pública vol.24 número4

... ± 5 years) from the various outpatient clin- ics in one of the selected referral ...ophthalmology, and ear, nose, and throat outpatient ...(20%), and other diagnoses in smaller ... See full document

9

Rev. Assoc. Med. Bras.  vol.58 número5

Rev. Assoc. Med. Bras. vol.58 número5

... with breast cancer were retrospectively ...p53, and Ki67. he analysis of the concordance between CNB and surgical biopsy was performed using the kappa (k) coeicient (95% ...labeling in ... See full document

5

RAD51B in Familial Breast Cancer.

RAD51B in Familial Breast Cancer.

... Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark, 29 Human Cancer Genetics Program, Spanish National Cancer Research Centre, Madrid, Spain, 30 Centro de Investigación en Red ... See full document

18

TOX3 mutations in breast cancer.

TOX3 mutations in breast cancer.

... support and reject the tumour suppressor role of ...rs3803662 and lower expression of TOX3 in an allele-specific manner ...grade and poorer outcome ...rs3803662 in Luminal A tumours, ... See full document

5

Rev. Hosp. Clin.  vol.58 número2

Rev. Hosp. Clin. vol.58 número2

... did not know their clinical stage when compared to those who did know ...(75.9%), and we ob- served a tendency to accept HRT among those with advanced stage, al- though without statistical significance ... See full document

6

Population prevalence of hereditary breast cancer phenotypes and implementation of a genetic cancer risk assessment program in southern Brazil

Population prevalence of hereditary breast cancer phenotypes and implementation of a genetic cancer risk assessment program in southern Brazil

... Vento, in a partnership with Ins- tituto da Mama do Rio Grande do Sul (IMAMA-RS) and the Municipal Health Agency of Porto ...Reyes and the NMPOA team for help with the recruitment, evaluation ... See full document

9

Metformin Decouples Phospholipid Metabolism in Breast Cancer Cells.

Metformin Decouples Phospholipid Metabolism in Breast Cancer Cells.

... detected in each cell line treated with metformin, but the magnitude of the effect was greater in MDA-MB-468 and BT474 cells than in SKBr3 ...beneficial in patients refractory to ... See full document

17

A case report of male breast cancer in a very young patient: What is changing?

A case report of male breast cancer in a very young patient: What is changing?

... tion in August 2007 complaining of a breast tumor of progressive growth for the previous eight ...medical and family history did not appear to con- tribute to the present ...steroids ... See full document

5

Multivariate analyses to assess the effects of surgeon and hospital volume on cancer survival rates: a nationwide population-based study in Taiwan.

Multivariate analyses to assess the effects of surgeon and hospital volume on cancer survival rates: a nationwide population-based study in Taiwan.

... of cancer surgery to medical centers or high-volume ...organizations and payers, such as the Bureau of National Health Insurance, may sponsor clinical quality improvement research to identify care ... See full document

10

Modelos de co-culturas de células in vitro para desenvolvimento de novos sistemas de entrega de fármacos

Modelos de co-culturas de células in vitro para desenvolvimento de novos sistemas de entrega de fármacos

... Os recentes avanços na área da Nanotecnologia abriram novas oportunidades para o desenvolvimento de novos nano-sistemas como as nanopartículas para entrega de fármacos ou de informação genética com potencial para serem ... See full document

104

Rev. bras. epidemiol.  vol.20 número4

Rev. bras. epidemiol. vol.20 número4

... RESUMO: Introdução: A hormonioterapia no câncer de mama é fundamental para a transição do tratamento ativo aos cuidados de sobrevivência, pois melhora signiicativamente os resultados de sobrevida em longo prazo, além de ... See full document

14

Estrogen induces Vav1 expression in human breast cancer cells.

Estrogen induces Vav1 expression in human breast cancer cells.

... Human breast cancer cell lines (ER positive: MCF7 and T47D; ER negative: MDA-MB-231 and MDA-MB-157) were originally from American Type Culture Collection (ATCC) and maintained in ... See full document

11

Show all 10000 documents...